Overview

A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the effect of Nestorone (NES) administered as an bolus injection on the corrected QT interval using Fridericia's formula (QTcF).

Phase:

Phase 1

Details

Lead Sponsor:

Population Council

Collaborator:

Parexel

Treatments:

Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
ST 1435